Title : Clinical trial support

Client Situation

An oncology focused biopharmaceutical company was conducting a clinical study to evaluate the safety of one of its drugs used for the reduction in duration of neutropenia in breast cancer patients undergoing chemotherapy. The study was a one year phase III multicenter trial across 20 centers and 120 subjects in 9 countries and a follow-up period of 6 months. The client selected Sciformix to support case processing for this trial.